Monoclonal antibody
Type Whole antibody
Source Human
Target CD40
Clinical data
ATC code none
CAS Number 903512-50-5 N
ChemSpider none
KEGG D08942 YesY
Chemical and physical data
Molar mass 146 kg/mol
 NYesY (what is this?)  (verify)

Lucatumumab is a human monoclonal antibody[1] being investigated for the treatment of various types of cancer like multiple myeloma,[2] non-Hodgkin's or Hodgkin's lymphoma.[3]

This drug was developed by Novartis Pharmaceuticals Corp.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council – Lucatumumab, American Medical Association.
  2. Clinical trial number NCT00231166 at
  3. Clinical trial number NCT00670592 at

This article is issued from Wikipedia - version of the 9/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.